课题基金 / 基金详情

Biotinylated Monoclonal Antibody Conjugated to Gadolinium as a Contrast Agent for Magnetic Resonance Imaging of Human Rectal Carcinoma

Biotinylated Monoclonal Antibody Conjugated to Gadolinium as a Contrast Agent for Magnetic Resonance Imaging of Human Rectal Carcinoma
生物素化单克隆抗体与钆缀合作为人直肠癌磁共振成像的造影剂
批准号:
17591429
负责人:
OTSUJI Eigo
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

OTSUJI Eigo的其他基金

相似基金

相关文献

中文摘要
翻译
局部病变是直肠癌最常见的复发方式,预后不佳。为了尽早发现局部复发,我们制备了单抗A7-Gd结合物作为磁共振成像的造影剂,用于区分肿瘤和正常组织。我们检测了单抗A7与Gd通过螯合、异硫氰基苯基EDTA偶联的体外免疫反应性及其在裸鼠体内的分布,单抗A7-Gd保持了与完整单抗A7几乎相同的结合活性。放射性标记单抗A7-Gd在肿瘤中的积聚多于正常小鼠的Ig G-Gd。单抗A7-Gd和正常小鼠免疫球蛋白-Gd均随时间线性消失。在正常组织中的蓄积量随时间呈线性下降,但低于在肿瘤中的蓄积量。注射亲和素后,生物素化chA7Fab在血液和肾脏中的蓄积量显着减少。
英文摘要
Local disease is the most frequent recurrence pattern of rectal carcinoma, and its prognosis is not good. To detect local recurrence as early as possible, we produced the monoclonal antibody A7-gadolinium (Mab A7-Gd) conjugate as a contrast agent for magnetic resonance imaging to distinguish between carcinoma and normal tissue.We examined the in vitro immunoreactivity of Mab A7 coupled to Gd by chelate, isothiocyanobenzyl EDTA and its in vivo distribution in nude mice with human colorectal carcinoma.Mab A7-Gd retained binding activities that were nearly identical to intact Mab A7. More radiolabelled Mab A7-Gd accumulated in the tumor than normal mouse IgG-Gd. Both Mab A7-Gd and normal mouse IgG-Gd disappeared from blood linearly over time. Accumulation levels in normal tissues decreased linearly over time but were lower than those in tumors.The accumulation of biotinylated chA7Fab in the blood and the kidneys decreased significantly after the injection of avidin.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Monoclonal Antibody conjugated to Gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma.
与钆缀合的单克隆抗体作为人类直肠癌磁共振成像的造影剂。
DOI: --
发表时间:
期刊: J Surg Oncol (In press)
影响因子: --
作者: [Kuriu Y, Otsuji E, 他]
通讯作者: 他
DOI: 10.1038/sj.bjc.6602668
发表时间: 2005-07-11
期刊: British journal of cancer
影响因子: 8.8
作者: []
通讯作者:
DOI: 10.1007/s00262-005-0067-9
发表时间: 2006-06-01
期刊: CANCER IMMUNOLOGY IMMUNOTHERAPY
影响因子: 5.8
作者: [Otsuji,E, Kuriu,Y, Yamagishi,H]
通讯作者: Yamagishi,H
Monoclonal Antibody Conjugated to Gadolinium as a Contrast Agent for Magnetic Resonance Imaging of Human Rectal Carcinoma
  • 批准号:
    15591428
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    OTSUJI Eigo
  • 依托单位:
Monoclonal Antibody A7 Coupled to Magnetic Particles as a Contrast
  • 批准号:
    13671327
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2001
  • 负责人:
    OTSUJI Eigo
  • 依托单位:
Chimeric monoclonal antibody A7-Fab coupled to magnetic particles as a contrast agent of MR imaging
  • 批准号:
    11671265
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    1999
  • 负责人:
    OTSUJI Eigo
  • 依托单位:
Immunoguided Surgery Using Monoclonal Antibody A7 Coupled to Magnetic Particles
  • 批准号:
    09671329
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.98万
  • 财政年份:
    1997
  • 负责人:
    OTSUJI Eigo
  • 依托单位:
国内基金
海外基金
多模态MRI脊髓微结构成像技术在脊髓型颈椎病诊治中的作用研究
  • 批准号:
    JCZRLH202601272
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于多模态MRI评估早期抑郁症患者脑类淋巴系统异常改变的研究
基于人工智能和多模态MRI的股骨头坏死塌陷风险预测研究
  • 批准号:
    JCZRLH202600607
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
靶向Na⁺-糖酵解轴:²³Na-MRI无创评估宫颈癌化疗耐药与疗效预测研究
  • 批准号:
    JCZRLH202600284
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: